Status:

COMPLETED

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Asthma

Eligibility:

All Genders

2-10 years

Phase:

PHASE4

Brief Summary

To compare the bronchodilator efficacy of ipratropium plus salbutamol (Combivent) with salbutamol alone given every 20 minutes for three doses in asthmatic children with severe acute exacerbation

Detailed Description

A Comparison of Ipratropium 500mcg and salbutamol 2.5mg (Combivent UDV) and salbutamol UDV alone (2.5mg) in a Double-blind, Efficacy and Safety Study in Asthmatic Children with Severe Acute Exacerbati...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • All patients must have a known history of asthma and present to the hospital/clinic with severe acute exacerbation.
  • Male or female patients 2 to 10 years of age.
  • Parents or legal guardians of patients must sign an Informed Consent Form prior to participation in the trial.
  • EXCLUSION CRITERIA
  • Patients with known or suspected hypersensitivity to study drugs
  • Patients with medical condition that would contraindicate the use of beta2-adrenergic or anticholinergic medications
  • Patients with first wheezing episode only
  • Prior intubation for asthma for more than 24 hours
  • Patients who used ipratropium within six hours prior to consultation
  • Patients with concurrent stridor or possible presence of intra-thoracic foreign body
  • Patients with disease known to have chronic effect on respiratory function ( e.g., cystic fibrosis or cardiac disease)
  • Patients requiring immediate resuscitation or airway intervention
  • With psychiatric disease or psychosocial problems
  • Patients on other investigational drugs or have used any other investigational drugs within the past month

Exclusion

    Key Trial Info

    Start Date :

    May 1 2002

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2003

    Estimated Enrollment :

    500 Patients enrolled

    Trial Details

    Trial ID

    NCT00273962

    Start Date

    May 1 2002

    End Date

    November 1 2003

    Last Update

    October 29 2013

    Active Locations (10)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (10 locations)

    1

    Jose Reyes Memorial Medical Center

    Manila, Philippines

    2

    Philippine General Hospital

    Manila, Philippines

    3

    Amang Rodriguez Hospital

    Marikina City, Philippines

    4

    San Juan de Dios Hospital

    Pasay, Philippines